Hangzhou Tigermed Consulting Co., Ltd (3347.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 32.9B |
| Enterprise Value | 32.6B |
| P/E Ratio | 660 |
| PEG Ratio | -8.63 |
| Price/Sales Ratio | 5.34 |
| Price/Book Ratio | 2.27 |
| Enterprise/Revenue | 5.39 |
| Enterprise/EBITDA | 25.64 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.01 |
| Operating Margin | 0.16 |
AD
Management Effectiveness
| Return On Assets | 0 |
| Return On Equity | 0 |
Income Statement
| Revenue | 6.83B |
| Revenue/Share | 8.72 |
| Gross Profit | 1.87B |
| EBITDA | 1.42B |
| Net Income | 887.89M |
| Diluted EPS | 1.03 |
Balance Sheet
| Total Cash | 2.15B |
| Total Cash/Share | 2.57 |
| Total Debt | 2.35B |
| Total Debt/Equity | 0.12 |
| Current Ratio | 2.49 |
| Book Value Per Share | 27.63 |
Price History
| 52-Week Change | -9.01 |
| 52-Week High | 57 |
| 52-Week Low | 28.12 |
| Moving Average 50 Days | 38.85 |
| Moving Average 200 Days | 41.05 |
Statistics
| Average Volume | 2M |
| Shares Outstanding | 1.21B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.13 |
| Trailing Annual Dividend Yield | 0.24 |
| Payout Ratio | 0.95 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
